Related Experiment Video
Updated: Aug 19, 2025

Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
Harnessing Normal and Engineered Mesenchymal Stem Cells Derived Exosomes for Cancer Therapy: Opportunity and
Mahdi Ahmadi1, Monireh Mahmoodi2, Maryam Shoaran3
1Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz 5665665811, Iran.
Abstract:
There remains a vital necessity for new therapeutic approaches to combat metastatic cancers, which cause globally over 8 million deaths per year. Mesenchymal stem cells (MSCs) display aptitude as new therapeutic choices for cancer treatment. Exosomes, the most important mediator of MSCs, regulate tumor progression. The potential of harnessing exosomes from MSCs (MSCs-Exo) in cancer therapy is now being documented. MSCs-Exo can promote tumor progression by affecting tumor growth, metastasis, immunity, angiogenesis, and drug resistance. However, contradictory evidence has suggested that MSCs-Exo suppress tumors through several mechanisms. Therefore, the exact association between MSCs-Exo and tumors remains controversial. Accordingly, the applications of MSCs-Exo as novel drug delivery systems and standalone therapeutics are being extensively explored. In addition, engineering MSCs-Exo for targeting tumor cells has opened a new avenue for improving the efficiency of antitumor therapy. However, effective implementation in the clinical trials will need the establishment of standards for MSCs-Exo isolation and characterization as well as loading and engineering methods. The studies outlined in this review highlight the pivotal roles of MSCs-Exo in tumor progression and the promising potential of MSCs-Exo as therapeutic drug delivery vehicles for cancer treatment.
Insights
Mesenchymal stem cell-derived exosomes (MSCs-Exo) show dual roles in cancer, potentially promoting or suppressing tumors. Further research and standardization are crucial for their therapeutic application in cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Biotechnology
Background:
- Metastatic cancers cause over 8 million deaths annually, necessitating novel therapeutic strategies.
- Mesenchymal stem cells (MSCs) and their derived exosomes (MSCs-Exo) are emerging as potential cancer therapeutics.
- The precise role of MSCs-Exo in tumor progression remains controversial, with evidence suggesting both pro- and anti-tumorigenic effects.
Purpose of the Study:
- To review the multifaceted roles of MSCs-Exo in tumor progression, including effects on growth, metastasis, immunity, angiogenesis, and drug resistance.
- To explore the potential of MSCs-Exo as standalone therapeutics and drug delivery systems for cancer treatment.
- To highlight the importance of engineering MSCs-Exo for targeted cancer therapy and discuss challenges for clinical translation.
Main Methods:
- Literature review of studies investigating the interaction between MSCs-Exo and various cancers.
- Analysis of evidence for both tumor-promoting and tumor-suppressing mechanisms mediated by MSCs-Exo.
- Examination of current strategies for MSCs-Exo isolation, characterization, loading, and engineering.
Main Results:
- MSCs-Exo exhibit complex regulatory functions in cancer, influencing tumor growth, metastasis, immune evasion, angiogenesis, and drug resistance.
- Contradictory findings exist regarding MSCs-Exo's impact on tumors, underscoring the need for further clarification.
- Engineering MSCs-Exo offers a promising approach to enhance their antitumor efficacy through targeted delivery.
Conclusions:
- MSCs-Exo play pivotal roles in tumor progression, presenting both challenges and opportunities for cancer therapy.
- Harnessing MSCs-Exo as drug delivery vehicles or standalone agents holds significant therapeutic promise.
- Standardization of isolation, characterization, and engineering methods is essential for the successful clinical implementation of MSCs-Exo-based cancer therapies.
More Related Videos
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
12:02Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells
Published on: November 11, 2021
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Clinical Applications of Epidermal Stem Cells
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...